Overall, these data provide mechanistic explanation for the involvement of PI3K/mTOR signaling in cells harboring the JAK2V617F mutation and might be translationally relevant for designing innovative strategies in MPN. The gene discussed is MTOR; the disease is myeloproliferative disorder.